Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GH Guardant Health Inc.

已收盘 02-13 16:00:00 EST

104.85

+2.09

+2.03%

盘后105.13

+0.28+0.27%

18:10 EST

最高106.42	最低102.75	成交量104.66万
今开102.90	昨收102.76	日振幅3.57%
总市值135.65亿	流通市值130.01亿	总股本1.29亿
成交额1.10亿	换手率0.84%	流通股本1.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":104.85,"timestamp":1771016400000,"preClose":102.76,"halted":0,"volume":1046562,"hourTrading":{"tag":"盘后","latestPrice":105.1305,"preClose":104.85,"latestTime":"18:10 EST","volume":165012,"amount":17305506.558,"timestamp":1771024255526,"change":0.2805,"changeRate":0.002675,"amplitude":0.002675},"delay":0,"changeRate":0.020338653172440532,"floatShares":124000000,"shares":129374422,"eps":-3.212374,"marketStatus":"已收盘","change":2.09,"latestTime":"02-13 16:00:00 EST","open":102.9,"high":106.42,"low":102.75,"amount":110023053.66096,"amplitude":0.035714,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.212374,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":102.76,"preHourTrading":{"tag":"盘前","latestPrice":102.64,"preClose":102.76,"latestTime":"09:29 EST","volume":418,"amount":42363.418020000005,"timestamp":1770992999908,"change":-0.12,"changeRate":-0.001168,"amplitude":0.017127},"postHourTrading":{"tag":"盘后","latestPrice":105.1305,"preClose":104.85,"latestTime":"18:10 EST","volume":165012,"amount":17305506.558,"timestamp":1771024255526,"change":0.2805,"changeRate":0.002675,"amplitude":0.002675},"volumeRatio":0.596683,"impliedVol":0.7609,"impliedVolPercentile":0.9084},"requestUrl":"/m/hq/s/GH/wiki","defaultTab":"wiki","newsList":[{"id":"1185436235","title":"财报前瞻｜Guardant Health Inc.营收预计强劲增长，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1185436235","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185436235?lang=zh_cn&edition=full","pubTime":"2026-02-12 10:24","pubTimestamp":1770863073,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.将于2026年02月19日发布业绩，市场共识预计营收延续高增，亏损率收窄，核心产品渗透扩大成看点。公司目前主营业务亮点在于肿瘤学检测业务，受益于Guardant360与TissueNext在医院端与生物制药客户渗透，带动流水扩大。来自机构的最新观点更偏向看多阵营，占比高于看空观点。某些华尔街机构指出，“随着生物制药合作订单的稳定落地与核心检测项目扩容，Guardant Health Inc.的收入增长确定性较强，若指引印证高增与费用纪律，股价具备进一步修复空间。”","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Guardant Health Inc.营收预计强劲增长，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"gpt_icon":0},{"id":"2609549637","title":"Guardant Health, Inc.涨2.82% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2609549637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609549637?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:35","pubTimestamp":1770388511,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时35分，Guardant Health, Inc.股票出现波动，股价快速拉升2.82%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.19%。其相关个股中，Ispecimen Inc.、Inotiv, Inc.、Personalis, Inc.涨幅较大，Ispecimen Inc.、Xwell, Inc.、Bioaffinity Technologies, Inc.较为活跃，换手率分别为91.58%、0.54%、0.19%，振幅较大的相关个股有Xwell, Inc.、Ispecimen Inc.、Check-Cap Ltd.，振幅分别为10.42%、10.29%、5.66%。Guardant Health, Inc.公司简介：总部位于加州红木城的Guardant Health是临床和研究用液体癌症检测的领导者。2021年，Guardant推出了Reveal，这是一种与肿瘤无关的分子残留疾病测试。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223511a6dc0cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223511a6dc0cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4196","BK4551","BK4585","GH","BK4588"],"gpt_icon":0},{"id":"2606246128","title":"维升药业隆培生长激素获批：1年长高11厘米，百亿市场格局生变","url":"https://stock-news.laohu8.com/highlight/detail?id=2606246128","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606246128?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:13","pubTimestamp":1769436796,"startTime":"0","endTime":"0","summary":"1月26日，国家药品监督管理局（NMPA）正式批准维升药业（2561.HK）的核心产品——隆培生长激素注射液上市，该产品用于治疗儿童生长激素缺乏症（PGHD）。这款每周注射一次的长效生长激素，是国内首个且唯一经三期临床试验证实，其疗效优于日制剂的产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601263631011723.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601263631011723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4196","GH","BK4588","BK4551","BK4535"],"gpt_icon":0},{"id":"1191355671","title":"Guardant Health公司Guardant360® Cdx获FDA批准 作为Braftovi®（Encorafenib）联合疗法在BRAF V600E突变转移性结直肠癌患者中的伴随诊断","url":"https://stock-news.laohu8.com/highlight/detail?id=1191355671","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191355671?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:07","pubTimestamp":1769087239,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已正式批准Guardant Health公司旗下液体活检产品Guardant360 Cdx，将其作为Braftovi联合疗法用于BRAF V600E突变型转移性结直肠癌患者的伴随诊断工具。Guardant360 Cdx作为一种基于血液的检测方法，能够通过简单抽血即可识别出适合接受靶向治疗的患者群体，为传统组织活检提供了一种微创替代方案。此次获批意味着，临床医生现在可以依据该检测结果，为携带BRAF V600E突变的转移性结直肠癌患者制定包含Braftovi的个性化联合治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4196","GH","BK4588","BK4551","BK4535"],"gpt_icon":0},{"id":"1124929599","title":"Guardant Health与Trial Library达成合作，提升美国癌症临床试验的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1124929599","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124929599?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:06","pubTimestamp":1765458406,"startTime":"0","endTime":"0","summary":"Guardant Health与Trial Library达成合作，提升美国癌症临床试验的可及性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4196","BK4551","BK4588","BK4585","BK4535"],"gpt_icon":0},{"id":"1176561683","title":"Guardant Health 拟发行 3 亿美元可转换高级票据，到期时间为2033年","url":"https://stock-news.laohu8.com/highlight/detail?id=1176561683","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176561683?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:40","pubTimestamp":1763570401,"startTime":"0","endTime":"0","summary":"Guardant Health Inc. :: Guardant Health 拟发行 3 亿美元的可转换高级票据，到期时间为2033年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4535","GH","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"1140042890","title":"Guardant Health：肿瘤信号上升使疾病进展早至18个月，平均提前时间为2.3个月","url":"https://stock-news.laohu8.com/highlight/detail?id=1140042890","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140042890?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:07","pubTimestamp":1762434465,"startTime":"0","endTime":"0","summary":"Guardant Health：肿瘤信号上升使疾病进展早至18个月，平均提前时间为2.3个月","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GH","BK4535","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"1122589719","title":"Guardant Health：肿瘤信号减少超过98%的患者获得了显著益处","url":"https://stock-news.laohu8.com/highlight/detail?id=1122589719","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122589719?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:07","pubTimestamp":1762434460,"startTime":"0","endTime":"0","summary":"Guardant Health：肿瘤信号减少超过98%的患者获得了显著益处","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GH","BK4535","BK4551","BK4585","BK4588"],"gpt_icon":0},{"id":"1197091170","title":"异动解读 | Guardant Health股价盘中大跌8.77%，6.5亿美元融资计划引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1197091170","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197091170?lang=zh_cn&edition=full","pubTime":"2025-11-05 23:46","pubTimestamp":1762357612,"startTime":"0","endTime":"0","summary":"精准肿瘤学公司Guardant Health今日盘中大跌8.77%，延续了昨日夜间和今日盘前的跌势。这一显著跌幅主要源于公司最新宣布的大规模融资计划。据悉，Guardant Health于昨日收盘后宣布了一项重大融资计划。公司拟发行3亿美元的新股，同时还将非公开发行3.5亿美元、2033年到期的0%可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1145268630","title":"异动解读 | Guardant Health股价盘前大跌6.15%，新股发行和可转债计划引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1145268630","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145268630?lang=zh_cn&edition=full","pubTime":"2025-11-05 17:46","pubTimestamp":1762336011,"startTime":"0","endTime":"0","summary":"周三盘前，精准肿瘤学公司Guardant Health股价大跌6.15%，延续了周二夜间交易时的跌势。这一显著跌幅主要源于公司最新宣布的大规模融资计划。据悉，Guardant Health于周二收盘后宣布了一项重大融资计划。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。值得注意的是，尽管短期内股价承压，但Guardant Health的长期表现仍然强劲。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1196560654","title":"异动解读 | Guardant Health夜盘大跌7.59%，新股和可转债发行计划引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1196560654","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196560654?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:15","pubTimestamp":1762305304,"startTime":"0","endTime":"0","summary":"精准肿瘤学公司Guardant Health在夜盘交易中股价大幅下跌7.59%，引发市场广泛关注。这一显著跌幅主要源于公司最新宣布的大规模融资计划。据悉，Guardant Health计划发行2.5亿美元的新股，同时非公开发行3亿美元、2033年到期的可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。尽管短期内股价承压，但Guardant Health的长期表现仍然强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1129896298","title":"异动解读 | Guardant Health盘后大跌8.55%，拟发行新股和可转债","url":"https://stock-news.laohu8.com/highlight/detail?id=1129896298","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129896298?lang=zh_cn&edition=full","pubTime":"2025-11-05 06:32","pubTimestamp":1762295540,"startTime":"0","endTime":"0","summary":"周二盘后交易中，精准肿瘤学公司Guardant Health股价大幅下跌8.55%，引发投资者关注。据悉，Guardant Health宣布了一项重大融资计划。公司拟发行2.5亿美元的新股，同时还将非公开发行3亿美元2033年到期的可转换债券。公司表示，此次融资所得将用于一般企业用途，包括回购部分2027年到期的0%可转换债券，以及潜在的互补产品和技术收购。值得注意的是，Guardant Health目前已发行股票约1.26亿股，市值约124亿美元。尽管公司股价在盘后出现大幅下跌，但Guardant Health的长期表现依然强劲。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1137640606","title":"异动解读 | 盘中飙升27.45%，Guardant Health财报超预期提振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1137640606","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137640606?lang=zh_cn&edition=full","pubTime":"2025-10-30 22:03","pubTimestamp":1761833006,"startTime":"0","endTime":"0","summary":"癌症检测公司Guardant Health周四盘中股价大涨27.45%，创下近期新高。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期，极大提振了投资者信心。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，明显高于分析师预期的2.357亿美元。受此利好消息影响，多家券商纷纷上调了Guardant Health的目标价。分析师普遍认为，Guardant Health在癌症液体活检技术领域的领先地位，以及其业务的持续改善，将为公司未来的增长提供强劲动力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"29d42f0ac458daa518aec51f8817eeb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1139818900","title":"异动解读 | 业绩超预期，Guardant Health盘前大涨20.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139818900","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139818900?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:10","pubTimestamp":1761811821,"startTime":"0","endTime":"0","summary":"癌症检测公司Guardant Health Inc.周四盘前股价大涨20.73%，引发市场广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，明显高于分析师预期的2.357亿美元。Guardant Health是一家专注于癌症检测和诊断的生物科技公司，其液体活检技术在市场上备受关注。此外，Canaccord Genuity将公司的目标价从75美元上调至100美元，进一步提振了投资者信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"29d42f0ac458daa518aec51f8817eeb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":1},{"id":"1174423868","title":"异动解读 | 财报超预期，Guardant Health夜盘大涨21.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174423868","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174423868?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:30","pubTimestamp":1761784244,"startTime":"0","endTime":"0","summary":"周三夜盘，癌症检测公司Guardant Health Inc.股价大涨21.77%，引发市场广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，明显高于分析师预期的2.357亿美元。Guardant Health是一家专注于癌症检测和诊断的生物科技公司，其液体活检技术在市场上备受关注。此次超预期的财报结果不仅显示了公司业务的显著改善，也可能反映出其在癌症诊断领域的市场份额正在扩大。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"29d42f0ac458daa518aec51f8817eeb0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":1},{"id":"1160061473","title":"异动解读 | 业绩超预期，Guardant Health盘后大涨11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160061473","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160061473?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:34","pubTimestamp":1761770042,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.今日盘后股价大涨11.11%，引起投资者广泛关注。这一显著涨幅主要源于公司发布的第三季度财报优于市场预期。根据公司公布的财报显示，Guardant Health第三季度收入达到2.652亿美元，超过分析师预期的2.357亿美元。Guardant Health是一家专注于癌症检测和诊断的生物科技公司，其液体活检技术在市场上备受关注。此次超预期的财报结果不仅显示了公司业务的强劲增长，也可能反映出其在癌症诊断领域的市场份额正在扩大。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"gpt_icon":0},{"id":"1176722378","title":"Guardant Health 第三季度调整后每股亏损 USD -0.39，超出 IBES 预期 USD -0.76","url":"https://stock-news.laohu8.com/highlight/detail?id=1176722378","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176722378?lang=zh_cn&edition=full","pubTime":"2025-10-30 04:26","pubTimestamp":1761769600,"startTime":"0","endTime":"0","summary":"10月29日 - Guardant Health 第三季度收入为 2.652 亿美元，而 IBES 预期为 2.357 亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4196","BK4551","BK4588","BK4585","BK4535"],"gpt_icon":0},{"id":"1153214292","title":"Guardant Health与Zephyr AI宣布合作，以解锁药物反应预测和生物标志物洞察","url":"https://stock-news.laohu8.com/highlight/detail?id=1153214292","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153214292?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:07","pubTimestamp":1761566829,"startTime":"0","endTime":"0","summary":"Guardant Health与Zephyr AI宣布合作，以解锁药物反应预测和生物标志物洞察","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","BK4535","BK4196","BK4588","GH"],"gpt_icon":0},{"id":"1143810963","title":"FDA批准Guardant360® Cdx作为Eli Lilly and Company公司Inluriyo™（Imlunestrant）的伴随诊断产品，用于治疗ESR1突变晚期乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1143810963","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143810963?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:06","pubTimestamp":1759147597,"startTime":"0","endTime":"0","summary":"FDA批准Guardant360® Cdx作为Eli Lilly and Company公司Inluriyo™（Imlunestrant）的伴随诊断产品，用于治疗ESR1突变晚期乳腺癌","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4588","BK4196","BK4551","GH","BK4585"],"gpt_icon":0},{"id":"2568256415","title":"Guardant Health, Inc.盘中异动 大幅拉升5.06%报58.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568256415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568256415?lang=zh_cn&edition=full","pubTime":"2025-09-18 00:24","pubTimestamp":1758126256,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日00时24分，Guardant Health, Inc.股票出现异动，股价大幅上涨5.06%。Guardant Health, Inc.股票所在的生命科学行业中，整体跌幅为0.16%。其相关个股中，Prenetics Global、Advanced Biomed Inc.、Guardant Health, Inc.涨幅较大，Bioaffinity Technologies, Inc.、Check-Cap Ltd.、Ispecimen Inc.较为活跃，换手率分别为45.83%、32.59%、19.43%，振幅较大的相关个股有Genedx Holdings Corp C/Wts 22/07/2026 、Check-Cap Ltd.、Advanced Biomed Inc.，振幅分别为27.11%、20.63%、15.57%。Guardant Health, Inc.公司简介：Guardant Health, Inc总部位于加州红木城，是临床和研究用液体癌症检测的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918002416a4cbfc3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918002416a4cbfc3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4213","GH","LU0266512127.USD","LU0456854461.SGD","BK4585","BK4535","BK4196","BK4551","CRC","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":0.0447},{"period":"1month","weight":-0.0386},{"period":"3month","weight":0.0889},{"period":"6month","weight":0.7452},{"period":"1year","weight":1.2644},{"period":"ytd","weight":0.0061}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Guardant Health, Inc.于2011年12月在特拉华州注册成立。该公司是一家领先的精密肿瘤学公司，致力于通过使用其专有血液测试，大量数据集和高级分析来帮助全球征服癌症。Guardant Health, Inc.认为征服癌症的关键是在疾病的所有阶段前所未有地获取其分子信息，他们打算通过常规抽血或液体活检来实现。Guardant Health Guardant Health Oncology Platform旨在利用其在技术，临床开发，监管和报销方面的能力来推动商业应用，改善患者临床结果并降低医疗成本。为了实现他们在疾病的各个阶段管理癌症的目标，该公司已经开展了他们的液体活检测试，Guardant360和GuardantOMNI，用于治疗晚期癌症，为公司开展复发和早期检测测试的程序提供动力，分别为LUNAR-1和LUNAR- 2。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.043863},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.023739},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.017651},{"month":5,"riseRate":0.571429,"avgChangeRate":0.065461},{"month":6,"riseRate":0.714286,"avgChangeRate":0.081894},{"month":7,"riseRate":0.714286,"avgChangeRate":0.051469},{"month":8,"riseRate":0.571429,"avgChangeRate":0.08346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.065825},{"month":10,"riseRate":0.285714,"avgChangeRate":0.030366},{"month":11,"riseRate":0.75,"avgChangeRate":0.130427},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}